博九娱乐网

Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. They are focused on providing new treatment options for cardiometabolic diseases through there complementary, convenient, cost-effective product candidate gemcabene as add-on to the standard of care especially statins that will benefit…More patients, physicians, and payors.